Publicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas (9)

2023

  1. Evaluation of potential targets to enhance the sensitivity of cholangiocarcinoma cells to anticancer drugs

    Biomedicine and Pharmacotherapy, Vol. 168

  2. Impact of tumor suppressor genes inactivation on the multidrug resistance phenotype of hepatocellular carcinoma cells

    Biomedicine and Pharmacotherapy, Vol. 165

2022

  1. Mechanisms of Pharmacoresistance in Hepatocellular Carcinoma: New Drugs but Old Problems

    Seminars in Liver Disease, Vol. 42, Núm. 1, pp. 087-103

2020

  1. A novel serum metabolomic profile for the differential diagnosis of distal cholangiocarcinoma and pancreatic ductal adenocarcinoma

    Cancers, Vol. 12, Núm. 6

  2. Molecular bases of drug resistance in hepatocellular carcinoma

    Cancers, Vol. 12, Núm. 6, pp. 1-26

  3. Molecular bases of mechanisms accounting for drug resistance in gastric adenocarcinoma

    Cancers, Vol. 12, Núm. 8, pp. 1-29

2019

  1. Pharmacogenetics of hepatocellular carcinoma and cholangiocarcinoma

    Cancer Drug Resistance, Vol. 2, Núm. 3, pp. 680-709

  2. Role of transportome in the pharmacogenomics of hepatocellular carcinoma and hepatobiliary cancer

    Pharmacogenomics, Vol. 20, Núm. 13, pp. 957-970

2018

  1. Role of drug transporters in the sensitivity of acute myeloid leukemia to sorafenib

    Oncotarget, Vol. 9, Núm. 47, pp. 28474-28485